Ptsd429 发表于 2025-3-27 00:39:03

Submitted on: 24 November 2021.
Revised on: 30 January 2022.
Accepted on: 28 February 2022.

___________________Hematology Transfusion and Cell Therapy

BALK 发表于 2025-3-27 04:21:49

Submitted on: 11 February 2006.
Revised on: 10 April 2006.
Accepted on: 08 May 2006.

___________________Hematology Transfusion and Cell Therapy

faculty 发表于 2025-3-27 06:23:17

http://reply.papertrans.cn/2/113/11209/11209-33.png

从属 发表于 2025-3-27 13:18:19

Submitted on: 23 February 2023.
Revised on: 19 May 2023.
Accepted on: 10 July 2023.

___________________Hematology Transfusion and Cell Therapy

ellagic-acid 发表于 2025-3-27 16:35:08

http://reply.papertrans.cn/2/113/11209/11209-35.png

极小 发表于 2025-3-27 19:17:55

http://reply.papertrans.cn/2/113/11209/11209-36.png
页: 1 2 3 [4]
查看完整版本: ESCI期刊Hematology Transfusion and Cell Therapy 2024/2025影响因子:1.876 (HEMATOL TRANSF CELL) (2531-1379). (ONCOLOGY)(肿瘤学)Eme